Assessing the benefit of adjuvant chemotherapy for rectal cancer: a real-world analysis

被引：0
|
作者：
Hanna, Catherine R. [1 ]
de Wilt, Hans W. [2 ]
Downing, Amy [3 ,4 ]
Koeter, Tijmen [5 ]
Rutten, Harm J. T. [6 ]
van Erning, Felice [7 ]
Verheul, Henk M. W. [8 ]
Morris, Eva [9 ]
Muirhead, Rebecca [10 ]
机构：
[1] Univ Glasgow, Inst Canc Sci, CRUK Glasgow Clin Trials Unit, Glasgow, Lanark, Scotland
[2] Radboud Univ Nijmegen Med Ctr, Dept Surg, Nijmegen, Netherlands
[3] Univ Leeds, Inst Med Res St Jamess, Leeds, W Yorkshire, England
[4] Univ Leeds, Leeds Inst Data Analyt, Leeds, W Yorkshire, England
[5] Elisabeth TweeSteden Hosp, Dept Surg, Tilburg, Netherlands
[6] Catharina Hosp, Dept Surg, Eindhoven, Netherlands
[7] Netherlands Comprehens Canc Org, Dept Res & Dev, Utrecht, Netherlands
[8] Univ Med Ctr, Dept Med Oncol, Rotterdam, Netherlands
[9] Univ Oxford, Big Data Inst, Nuffield Dept Populat Hlth, Oxford, England
[10] Oxford Univ Hosp NHS Fdn Trust, Dept Oncol, Oxford, England
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
rectal; adjuvant; chemotherapy; PREOPERATIVE CHEMORADIOTHERAPY; OPEN-LABEL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
428
引用
收藏
页码：S1481 / S1483
页数：4
相关论文
共 50 条
  • [41] Clinical and Oncological Impact of a Protective Ileostomy in Rectal Cancer Patients Undergoing Adjuvant Chemotherapy
    Zadoroznyj, Alizee
    Karam, Elias
    Michot, Nicolas
    Thiery, Julien
    Lecomte, Thiery
    Moussata, Driffa
    Chapet, Sophie
    Calais, Gilles
    Salame, Ephrem
    Pabst-giger, Urs
    Ouaissi, Mehdi
    ANTICANCER RESEARCH, 2024, 44 (11) : 4995 - 5005
  • [42] Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit
    Thomas, Michelle L.
    Hewett, Peter J.
    Ruszkiewicz, Andrew R.
    Moore, James W. E.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (04) : 343 - 351
  • [43] Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world study
    Li, Haorui
    Guo, Yu
    Sun, Xugang
    Lu, Yang
    Chang, Shaofei
    Wang, Xiuchao
    Gao, Song
    Gao, Chuntao
    Zhao, Tiansuo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Real-World Data on the Practice of Chemoradiation with Select Cohort Consolidation Chemotherapy in High-Risk Locally Advanced Rectal Cancers (SOLAR study)
    Yallala, Mounika
    Krishnatry, Rahul
    Shah, Anjali
    Bhargava, Prabhat Ghanshyam
    Ramaswamy, Anant
    Baheti, Akshay
    Saklani, Avanish
    Engineer, Reena
    Ankathi, Suman K.
    Kazi, Mufaddal
    Desouza, Ashwin
    Ostwal, Vikas
    SOUTH ASIAN JOURNAL OF CANCER, 2025,
  • [45] Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data
    Chen, Yu-An
    Lai, Hsuan-Wen
    Su, Hui-Chen
    Loh, El-Wui
    Huang, Tsai-Wei
    Tam, Ka-Wai
    BREAST CANCER, 2024, 31 (05) : 739 - 753
  • [46] Factors associated with survival in small cell lung cancer: an analysis of real-world national audit, chemotherapy and radiotherapy data
    Jones, Gavin S.
    Khakwani, Aamir
    Pascoe, Abigail
    Foweraker, Karen
    McKeever, Tricia M.
    Hubbard, Richard B.
    Baldwin, David R.
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (04) : 4055 - +
  • [47] Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World Study
    Tasci, Elif Senocak
    Mutlu, Arda Ulas
    Saylik, Onur
    Olmez, Omer Fatih
    Bilici, Ahmet
    Sunger, Erdem
    Sutcuoglu, Osman
    Oksuzoglu, Omur Berna Cakmak
    Ozdemir, Nuriye
    Akdogan, Orhun
    Bayoglu, Ibrahim Vedat
    Majidova, Nargiz
    Guren, Ali Kaan
    Engin, Esra Ozen
    Hacibekiroglu, Ilhan
    Er, Ozlem
    Dane, Faysal
    Bozkurt, Mustafa
    Canbaz, Esra Turan
    Erdamar, Sibel
    Aytac, Erman
    Ozer, Leyla
    Yildiz, Ibrahim
    CANCERS, 2024, 16 (18)
  • [48] The real-world efficacy and safety of nivolumab plus chemotherapy in patients with HER2-negative advanced gastric cancer
    Liu, Yu-Yin
    Tsai, Ming-Yen
    Liu, Ting-Ting
    Liu, Yueh-Wei
    Lin, Yu-Hung
    Yeh, Cheng-Hsi
    Lin, Yu-Cheng
    Chen, Yen-Hao
    BMC CANCER, 2024, 24 (01)
  • [49] A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline-Taxane Chemotherapy in Early HER-2 Negative Breast Cancer
    Mata, Danilo Giffoni de Mello Morais
    Pezo, Rossanna C.
    Chan, Kelvin K. W.
    Menjak, Ines
    Eisen, Andrea
    Trudeau, Maureen
    CURRENT ONCOLOGY, 2025, 32 (01)
  • [50] Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer
    Tsavaris, N
    Gennatas, K
    Kosmas, C
    Skopelitis, HM
    Gouveris, P
    Dimitrakopoulos, A
    Zacharakis, M
    Kouraklis, G
    Vasiliou, J
    Felekouras, E
    Voros, D
    Zografos, G
    Balafouta, M
    Paraskevaidis, M
    Safioleas, M
    Fotiadis, K
    Papastratis, G
    Karatzas, G
    Papalambros, E
    ONCOLOGY REPORTS, 2004, 12 (04) : 927 - 932
12345